US Stock MarketDetailed Quotes

Citius Pharmaceuticals (CTXR)

Watchlist

0.8050
-0.0380-4.51%

Close Apr 10 16:00 ET

0.8231
+0.0181+2.25%

Post 18:52 ET

18.01MMarket Cap-0.33P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Citius Pharmaceuticals (CTXR) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Dec 31, 2025

(FY)Sep 30, 2025

(Q4)Sep 30, 2025

(Q3)Jun 30, 2025

(Q2)Mar 31, 2025

(Q1)Dec 31, 2024

(FY)Sep 30, 2024

(Q4)Sep 30, 2024

(Q3)Jun 30, 2024

(Q2)Mar 31, 2024

Total revenue

3.94M

Operating revenue

--3.94M

--0

Cost of revenue

789.21K

Gross profit

3.15M

Operating expense

21.26%12.17M

-8.26%38.53M

-23.65%8.44M

-17.36%8.79M

2.65%11.26M

7.48%10.04M

14.33%42M

9.14%11.05M

22.63%10.63M

2.67%10.97M

Selling and administrative expenses

26.39%10M

-2.39%29.37M

-16.47%6.8M

-8.94%7.17M

1.76%7.49M

17.77%7.91M

37.32%30.09M

12.34%8.14M

60.38%7.87M

23.59%7.36M

-General and administrative expense

26.39%10M

-2.39%29.37M

-16.47%6.8M

-8.94%7.17M

1.76%7.49M

17.77%7.91M

37.32%30.09M

12.34%8.14M

60.38%7.87M

23.59%7.36M

Research and development costs

-24.79%1.6M

-23.10%9.16M

-43.68%1.64M

-41.34%1.62M

4.45%3.77M

-18.87%2.13M

-19.66%11.91M

1.12%2.91M

-26.58%2.76M

-23.71%3.61M

Depreciation amortization depletion

--573.44K

----

--0

----

-Depreciation and amortization

--573.44K

----

--0

----

Operating profit

10.16%-9.02M

8.26%-38.53M

23.65%-8.44M

17.36%-8.79M

-2.65%-11.26M

-7.48%-10.04M

-14.33%-42M

-9.14%-11.05M

-22.63%-10.63M

-2.67%-10.97M

Net non-operating interest income expense

-588.50%-110.44K

-120.80%-157.7K

-135.88%-42.1K

-174.02%-151.63K

-92.64%13.41K

-91.09%22.61K

-35.73%758K

-63.88%117.31K

-39.18%204.84K

-39.92%182.21K

Non-operating interest income

99.47%45.1K

-85.48%110.08K

-54.46%53.42K

-89.93%20.64K

-92.64%13.41K

-91.09%22.61K

-35.73%758K

-63.88%117.31K

-39.18%204.84K

-39.92%182.21K

Non-operating interest expense

--155.54K

--267.78K

--95.52K

--172.26K

----

--0

----

--0

----

Other net income (expense)

-33.41%2.39M

2.39M

Other non- operating income (expenses)

----

-33.41%2.39M

--0

----

--2.39M

Income before tax

8.86%-9.13M

0.43%-38.68M

22.44%-8.48M

14.28%-8.94M

-33.89%-11.25M

-10.23%-10.02M

-21.53%-38.85M

-11.56%-10.93M

-25.12%-10.43M

19.09%-8.4M

Income tax

0.00%264.24K

83.50%1.06M

83.50%264.24K

0.00%576K

0.00%144K

Net income

8.63%-9.39M

-0.80%-39.74M

21.07%-8.74M

12.95%-9.2M

-34.73%-11.51M

-11.38%-10.28M

-21.15%-39.43M

-11.40%-11.08M

-24.70%-10.57M

18.83%-8.54M

Net income continuous Operations

8.63%-9.39M

-0.80%-39.74M

21.07%-8.74M

12.95%-9.2M

-34.73%-11.51M

-11.38%-10.28M

-21.15%-39.43M

-11.40%-11.08M

-24.70%-10.57M

18.83%-8.54M

Minority interest income

-128.68%-1.17M

-703.61%-2.31M

-173.30%-784.36K

-414K

-595K

-513K

-287K

Net income attributable to the parent company

15.84%-8.22M

4.36%-37.43M

26.24%-7.96M

16.87%-8.79M

-27.77%-10.92M

-5.82%-9.77M

-20.27%-39.14M

-8.51%-10.79M

-24.70%-10.57M

18.83%-8.54M

Preferred stock dividends

Other preferred stock dividends

-9.02%1.05M

-36.96%725.75K

321.56K

Net income attributable to common stockholders

15.84%-8.22M

6.85%-37.43M

30.88%-7.96M

19.32%-8.79M

-27.77%-10.92M

-5.82%-9.77M

-19.27%-40.19M

-3.79%-11.52M

-28.49%-10.89M

18.83%-8.54M

Basic earnings per share

70.77%-0.38

43.38%-3.38

72.47%-0.4405

49.04%-0.8

5.22%-1.27

10.34%-1.3

-7.18%-5.97

12.09%-1.6

-4.67%-1.57

23.43%-1.34

Diluted earnings per share

70.77%-0.38

43.38%-3.38

72.47%-0.4405

49.04%-0.8

5.22%-1.27

10.34%-1.3

-7.18%-5.97

12.09%-1.6

-4.67%-1.57

23.43%-1.34

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Dec 31, 2025	(FY)Sep 30, 2025	(Q4)Sep 30, 2025	(Q3)Jun 30, 2025	(Q2)Mar 31, 2025	(Q1)Dec 31, 2024	(FY)Sep 30, 2024	(Q4)Sep 30, 2024	(Q3)Jun 30, 2024	(Q2)Mar 31, 2024
Total revenue	3.94M	0	0	0	0	0	0	0	0	0
Operating revenue	--3.94M	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	789.21K					0
Gross profit	3.15M					0
Operating expense	21.26%12.17M	-8.26%38.53M	-23.65%8.44M	-17.36%8.79M	2.65%11.26M	7.48%10.04M	14.33%42M	9.14%11.05M	22.63%10.63M	2.67%10.97M
Selling and administrative expenses	26.39%10M	-2.39%29.37M	-16.47%6.8M	-8.94%7.17M	1.76%7.49M	17.77%7.91M	37.32%30.09M	12.34%8.14M	60.38%7.87M	23.59%7.36M
-General and administrative expense	26.39%10M	-2.39%29.37M	-16.47%6.8M	-8.94%7.17M	1.76%7.49M	17.77%7.91M	37.32%30.09M	12.34%8.14M	60.38%7.87M	23.59%7.36M
Research and development costs	-24.79%1.6M	-23.10%9.16M	-43.68%1.64M	-41.34%1.62M	4.45%3.77M	-18.87%2.13M	-19.66%11.91M	1.12%2.91M	-26.58%2.76M	-23.71%3.61M
Depreciation amortization depletion	--573.44K	----	----	----	----	--0	----	----	----	----
-Depreciation and amortization	--573.44K	----	----	----	----	--0	----	----	----	----
Operating profit	10.16%-9.02M	8.26%-38.53M	23.65%-8.44M	17.36%-8.79M	-2.65%-11.26M	-7.48%-10.04M	-14.33%-42M	-9.14%-11.05M	-22.63%-10.63M	-2.67%-10.97M
Net non-operating interest income expense	-588.50%-110.44K	-120.80%-157.7K	-135.88%-42.1K	-174.02%-151.63K	-92.64%13.41K	-91.09%22.61K	-35.73%758K	-63.88%117.31K	-39.18%204.84K	-39.92%182.21K
Non-operating interest income	99.47%45.1K	-85.48%110.08K	-54.46%53.42K	-89.93%20.64K	-92.64%13.41K	-91.09%22.61K	-35.73%758K	-63.88%117.31K	-39.18%204.84K	-39.92%182.21K
Non-operating interest expense	--155.54K	--267.78K	--95.52K	--172.26K	----	--0	----	----	--0	----
Other net income (expense)							-33.41%2.39M	0		2.39M
Other non- operating income (expenses)	----	----	----	----	----	----	-33.41%2.39M	--0	----	--2.39M
Income before tax	8.86%-9.13M	0.43%-38.68M	22.44%-8.48M	14.28%-8.94M	-33.89%-11.25M	-10.23%-10.02M	-21.53%-38.85M	-11.56%-10.93M	-25.12%-10.43M	19.09%-8.4M
Income tax	0.00%264.24K	83.50%1.06M	83.50%264.24K	83.50%264.24K	83.50%264.24K	83.50%264.24K	0.00%576K	0.00%144K	0.00%144K	0.00%144K
Net income	8.63%-9.39M	-0.80%-39.74M	21.07%-8.74M	12.95%-9.2M	-34.73%-11.51M	-11.38%-10.28M	-21.15%-39.43M	-11.40%-11.08M	-24.70%-10.57M	18.83%-8.54M
Net income continuous Operations	8.63%-9.39M	-0.80%-39.74M	21.07%-8.74M	12.95%-9.2M	-34.73%-11.51M	-11.38%-10.28M	-21.15%-39.43M	-11.40%-11.08M	-24.70%-10.57M	18.83%-8.54M
Minority interest income	-128.68%-1.17M	-703.61%-2.31M	-173.30%-784.36K	-414K	-595K	-513K	-287K	-287K	0	0
Net income attributable to the parent company	15.84%-8.22M	4.36%-37.43M	26.24%-7.96M	16.87%-8.79M	-27.77%-10.92M	-5.82%-9.77M	-20.27%-39.14M	-8.51%-10.79M	-24.70%-10.57M	18.83%-8.54M
Preferred stock dividends
Other preferred stock dividends		0	0	0			-9.02%1.05M	-36.96%725.75K	321.56K
Net income attributable to common stockholders	15.84%-8.22M	6.85%-37.43M	30.88%-7.96M	19.32%-8.79M	-27.77%-10.92M	-5.82%-9.77M	-19.27%-40.19M	-3.79%-11.52M	-28.49%-10.89M	18.83%-8.54M
Basic earnings per share	70.77%-0.38	43.38%-3.38	72.47%-0.4405	49.04%-0.8	5.22%-1.27	10.34%-1.3	-7.18%-5.97	12.09%-1.6	-4.67%-1.57	23.43%-1.34
Diluted earnings per share	70.77%-0.38	43.38%-3.38	72.47%-0.4405	49.04%-0.8	5.22%-1.27	10.34%-1.3	-7.18%-5.97	12.09%-1.6	-4.67%-1.57	23.43%-1.34
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

On the morning of the 11th local time, Pakistani officials confirmed that delegations from the United States and Iran will hold negotiations Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm